- UK biotech Adaptimmune raises $104m series A to build US-style company
- US Capitol Capsule: Time for optimism about Alzheimer's R&D?
- US Capitol Capsule: Medicare data 'rich' treasure; so stop focusing on costs
- Merck investing $450m to let NGM run the R&D show
COMMENT Other Informa Comment
- The EMA at 20: Guido Rasi looks at how the EU regulatory landscape might change over the next decade
- PROFILE: AstraZeneca's Mene Pangalos on yin and yang, not believing your own press, and his part in Soriot's vision